BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 36456194)

  • 1. Chlorogenic Acid Inhibits Epithelial-Mesenchymal Transition and Invasion of Breast Cancer by Down-Regulating LRP6.
    Xue W; Hao J; Zhang Q; Jin R; Luo Z; Yang X; Liu Y; Lu Q; Ouyang Y; Guo H
    J Pharmacol Exp Ther; 2023 Feb; 384(2):254-264. PubMed ID: 36456194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy.
    Cui Y; Zhao M; Yang Y; Xu R; Tong L; Liang J; Zhang X; Sun Y; Fan Y
    Acta Biomater; 2022 Oct; 152():380-392. PubMed ID: 36028199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial-mesenchymal transition.
    Deng QD; Lei XP; Zhong YH; Chen MS; Ke YY; Li Z; Chen J; Huang LJ; Zhang Y; Liang L; Lin ZX; Liu Q; Li SP; Yu XY
    Acta Pharmacol Sin; 2021 Sep; 42(9):1486-1497. PubMed ID: 33893396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin.
    Chen L; Mai W; Chen M; Hu J; Zhuo Z; Lei X; Deng L; Liu J; Yao N; Huang M; Peng Y; Ye W; Zhang D
    Pharmacol Res; 2017 Sep; 123():130-142. PubMed ID: 28712972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
    Zhang X; Zhu M; Wang H; Song Z; Zhan D; Cao W; Han Y; Jia J
    Gene; 2021 Jan; 766():145163. PubMed ID: 32980450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinobufotalin inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells through down-regulate β-catenin in vitro and in vivo.
    Li W; Pei S; Zhang X; Qi D; Zhang W; Dou Y; Yang R; Yao X; Zhang Z; Xie S; Fang D; Sun H
    Eur J Pharmacol; 2022 May; 922():174886. PubMed ID: 35292248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling.
    Bernaudo S; Salem M; Qi X; Zhou W; Zhang C; Yang W; Rosman D; Deng Z; Ye G; Yang BB; Vanderhyden B; Wu Z; Peng C
    Oncogene; 2016 Sep; 35(36):4816-27. PubMed ID: 26876206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROR2 promotes the epithelial-mesenchymal transition by regulating MAPK/p38 signaling pathway in breast cancer.
    Xu J; Shi J; Tang W; Jiang P; Guo M; Zhang B; Ma G
    J Cell Biochem; 2020 Oct; 121(10):4142-4153. PubMed ID: 32048761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT.
    Wang J; Cai H; Liu Q; Xia Y; Xing L; Zuo Q; Zhang Y; Chen C; Xu K; Yin P; Chen T
    Am J Chin Med; 2020; 48(3):703-718. PubMed ID: 32329642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.
    Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G
    Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLDN6 Suppresses Migration and Invasion of MCF-7 and SKBR-3 Breast Cancer Cells by Blocking the SMAD/Snail/MMP-2/9 Axis.
    Liu T; Jiang L; Bai Q; Wu S; Yu X; Wu T; Wang J; Zhang X; Li H; Zhao K; Wang L
    Bull Exp Biol Med; 2023 Jul; 175(3):376-381. PubMed ID: 37566248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD147 promotes breast cancer migration and invasion by inducing epithelial-mesenchymal transition via the MAPK/ERK signaling pathway.
    Li F; Wang J; Yan YQ; Bai CZ; Guo JQ
    BMC Cancer; 2023 Dec; 23(1):1214. PubMed ID: 38066486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.
    Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC
    Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition.
    Wang H; Sang M; Geng C; Liu F; Gu L; Shan B
    Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
    Kim J; Kong J; Chang H; Kim H; Kim A
    Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.